ABSTRACT: SB-209247 [(E)-3- [6-[[(2,6-
DMD #1677 Introduction
Numerous drugs containing a carboxylic acid group, and especially certain non-steroidal anti-inflammatory drugs (NSAID), have been associated with diverse clinical toxicities (Griffin and Scheiman, 2001 ). Thus hepatotoxicity, to divergent extents, is known for nearly all NSAID, although the proportion of hepatic versus non-hepatic side effects varies considerably between the drugs and hepatotoxicity is not exclusive to the carboxylate compounds (Merlani et al., 2001) . The liver damage is in most cases considered to derive from an idiosyncratic metabolic and/or immune reaction which is essentially independent of dose (Boelsterli, 2002; Bailey and Dickinson et al., 2003) . Some carboxylate drugs are also linked with rarer hypersensitivity reactions. In general, the symptomatic hepatotoxicity is uncommon, mild and reversible; only in exceptional instances does it result in fulminant liver failure.
SB-209247 [(E)-3-[6-[[(2,6-dichlorophenyl)-thio]methyl]-3-(2-phenylethoxy)-2-pyridinyl]-
2-propenoic acid; Fig. 1 ], an LTB 4 receptor antagonist with oral anti-inflammatory activity in mice (Daines et al., 1996; Davis et al., 2000) , was developed for the treatment of dermal inflammatory diseases. LTB 4 is a potent, pro-inflammatory, neutrophil activator, chemotactic agent and apoptosis regulator which is released from neutrophils and other leukocytes during physiological and pathophysiological inflammatory reactions (Crooks and Stockley, 1998) . Development of SB-209247 was discontinued when administration to beagle dogs at 60-1000 mg/kg/day (0.13-2.17 mmol/kg/day) for 28 days was associated with non-dose-dependant inflammatory hepatopathy; minimal hepatocellular necrosis being observed in the more severe cases (SmithKline Beecham DMD #1677 5 reactions attributable to the various types of leukotriene antagonist are not unknown in experimental animals and humans but there is presently no clear evidence for a generic association related to either pharmacological activity or the presence of a carboxylic acid function (Fretland et al., 1995; Chambers et al., 1999; Reinus et al., 2000) .
Several mechanisms have been proposed by which a carboxylic acid might cause hepatotoxicity (Boelsterli, 2002) . Some carboxylic acid drugs have the potential to initiate cell injury by acting directly on mitochondria (Boelsterli, 2003) . Additional cytotoxic actions might require bioactivation, mediated by either oxidative metabolism (Bort et al., 1999) or the conjugation reactions forming acyl-CoA thioesters and acyl glucuronides (Boelsterli, 2002; Bailey and Dickinson et al., 2003) . Ester-linked glucuronides have received particular attention because of their well documented ability to react with cellular proteins and DNA through nucleophilic addition or displacement. This adduction can result in perturbation of molecular and organeller activity (Sallustio and Holbrook, 2001) or the generation of neoantigens which instigate immune-mediated cytotoxicity (Bailey and Dickinson et al., 2003) . The cytotoxic or cytostatic actions of acyl glucuronides have in certain cases suggested direct effects of the conjugate (Sallustio et al., 1997; Seitz and Boelsterli, 1998; Bailey and Dickinson et al., 2003) .
Conjugation with D-glucuronic acid is a common route of elimination for carboxylic acids
and is catalysed by a number of hepatic UGT (Soars et al., 2001) . Biosynthetic (β-1-O-) acyl glucuronides (Bailey and Dickinson et al., 2003) are generically reactive, electrophilic compounds capable of undergoing facile hydrolysis to the agylcone, rearrangement via reversible acyl DMD #1677 6 from C-1 allows opening of the glucuronic acid ring to create an aldehyde intermediate and subsequent formation of glucuronide-protein adducts (Bailey and Dickinson, 2003) .
The propenoic acid moiety of SB-209247 and the absence of conspicuous, alternative conjugable groups make this drug a potential substrate for extensive acyl glucuronidation in vivo.
We have considered the possibility that it might be bioactivated in dogs via this pathway: there are instances of carboxylic acid drugs undergoing species-selective acyl glucuronidation by hepatic microsomes (Soars et al., 2001; Prueksaritanont et al., 2002) . The metabolism of SB-209247 and the compound's hepatocytotoxicity in vitro have been investigated with particular reference to comparative rates of glucuronidation and covalent binding to hepatocellular proteins. 131 units/µl) in 0.1 M sodium acetate buffer (pH 5) at 37 °C for 4 h. The hydrolysate was analysed by radiometric HPLC. Residues of radiolabeled material in tissues (brain, heart, kidneys, liver, lungs and spleen) were measured as described previously (Maggs et al., 2000) . Portions of liver (approximately 100 mg) were homogenised in Hanks' balanced salt solution, protein was precipitated from the homogenates with three volumes of acetonitrile (3 ml), and radiolabeled material bound irreversibly to the pelleted protein (750g for 15 min) was estimated by exhaustive solvent extraction as described below.
Stability of Acyl Glucuronide Metabolites. Bile (0-1 h collection) from a rat given This article has not been copyedited and formatted. The final version may differ from this version. (Tettey et al., 1999) and from the cordate lobe of adult male beagle dogs by a three-step perfusion technique derived from the method of Strom et al. (1982) . The viability of the cell suspensions, typically ≥ 88 % and ≥ 98 %, respectively, was determined by trypan blue exclusion.
Freshly isolated rat hepatocytes (2.4 × 10 6 viable cells/ml) suspended in Krebs-Henseleit buffer (pH 7.4) were incubated with [ Incubations were carried out on four separate occasions in rotating 50-ml round-bottom flasks at 37
°C under an atmosphere of O 2 and CO 2 (95:5, v/v) . [ 14 C]SB-209247 was also incubated in the absence of hepatocytes. After one or three hours, ice-cold acetonitrile (15 ml) was added to the incubations and they were placed on ice for 15 min. The resulting precipitate was sedimented at 750g, and the unbound radiolabeled material associated with it was extracted with acetonitrile (3 ml × 2). The supernatant and extracts were combined, evaporated to dryness under N 2 at 40 °C and reconstituted in acetonitrile (200 µl) for analysis by LC-MS and radiochromatography.
Freshly isolated dog hepatocytes in Williams' medium supplemented with new-born calf serum (10 %, v/v), insulin (0.1 µg/ml) and antibiotics (penicillin, streptomycin and neomycin sulphate; each 100 µg/ml) were seeded in six-well collagen-coated plates (5 x 10 5 cells/ml, 3 ml).
They were allowed to adhere under an atmosphere of O 2 and CO 2 (95:5, v/v) at 37 °C. The medium was changed to serum-and insulin-free Williams' medium, and the cells were incubated with
DMD #1677
were combined, evaporated to dryness under N 2 at 40 °C and reconstituted in acetonitrile (200 µl)
for analysis.
The cell pellets from both sets of incubations were retained for determination of irreversibly bound radiolabeled material.
Toxicity of SB-209247 to Rat and Dog Liver Slices. Precision-cut liver slices were prepared from one male beagle dog (10.5 kg) and two male Sprague-Dawley rats. The dog was anaesthetized with acepromazine and pentobarbital and then exsanguinated. The rats were euthanized with carbon dioxide and exsanguinated. Livers were kept in ice-cold Krebs-Henseleit buffer (pH 7.4) until they were processed. Briefly, 8-mm cores produced with a stainless steel coring tool were sliced with a Krumdieck precision slicer (Krumdieck et al., 1980 Slices were incubated in pre-warmed medium (1.7 ml) for 1 h to equilibrate. This was replaced with pre-warmed medium (1.7 ml) containing either dimethyl sulphoxide (1 %, v/v) , SB-209247 in dimethyl sulphoxide (final drug concentration: 10 µM, 100 µM or 1 mM) or acetaminophen dissolved directly in medium (final concentration: 27 or 90 mM). Slices were incubated in duplicate for 2, 4 or 24 h; after which the medium was removed and assayed for LDH leakage spectrophotometrically (Bergmeyer and Bernt, 1974) . Each slice was sonicated in phosphatebuffered saline (pH 7.4; 1 ml) on ice for 30 s to liberate the remaining LDH.
Preparation of Microsomes. Livers were removed from adult male Wistar rats immediately after they were killed by cervical dislocation and homogenised individually in two volumes of icecold 67 mM potassium phosphate buffer (pH 7.5) containing 0.15 M potassium chloride. Samples (10 -20 g) of frozen human and dog liver stored at -80 °C were also homogenised individually.
Microsomal fractions were prepared according to the method of Gill et al. (1995) . Protein
This article has not been copyedited and formatted. The final version may differ from this version. The protein was separated by centrifugation at 750g for 15 min. The extraction procedure was repeated with 3-ml volumes of acetonitrile (× 3), methanol and finally methanol:water (7:3, v/v) until negligible amounts of radioactivity were detected in the supernatant by liquid scintillation counting. The protein was then dissolved in 1 M NaOH (0.3 ml) by warming for 16 h at 50 °C.
Aliquots ( 13 360 automated sample injector (Kontron Instruments, Watford, Hertfordshire, UK) and a Kontron 325 system pump. The eluate was acetonitrile (10-70 % over 55 min) in 50 mM ammonium acetate (pH 6.9) at a flow rate of 0.9 ml/min. The eluent was monitored with a Kontron 332 UV detector (λ= 254 nm). Radiolabeled analytes were quantified with a Radiomatic A250 flow detector (Packard, Pangbourne, Berkshire, UK) as described previously (Maggs et al., 2000) .
Liquid Chromatography-Mass Spectrometry. A Quattro II mass spectrometer (Micromass MS Technologies, Manchester, UK) fitted with the standard co-axial electrospray source was used in the negative-ion mode except as indicated. The LC system consisted of two Jasco PU980 pumps (Jasco UK, Great Dunmow, Essex, UK) and a Jasco HG-980-30 mixing module. Analytes (≥ 50 × 10 -3 dpm for radiolabeled material) were resolved on a Zorbax 5-µm C-18
column with a gradient of acetonitrile (10-70 % over 55 min) in 50 mM ammonium acetate, pH 6.9.
The flow rate was 0.9 ml/min. Eluate split-flow to the LC-MS interface was ca. 40 µl/min.
Nitrogen was used as the nebulizing and drying gas. This article has not been copyedited and formatted. The final version may differ from this version. .98 ± 1.9 % and 6.05 ± 1.8 % (mean ± SEM, n=4) of the radioactivity was recovered in the first, second and third hourly collections of bile, respectively; the recovery over 0-5 h was 81.95 ± 6.9 %.
The liver contained 2.8 ± 1.5 % of the dose at 5 h. Of this, 36.8 ± 0.1 % (1.03 ± 0.14 % of the dose) remained associated with the precipitated protein fraction after exhaustive solvent extraction and was therefore judged to be bound irreversibly; representing approximately 25 nmol equivalents/g liver. Less than 0.5 % of the dose was found in each of the following organs: brain, heart, kidneys, lungs and spleen.
Two major radiolabeled biliary metabolites (II and IV) were resolved by HPLC ( Fig. 2A ; Table 1 ). The same metabolites were found in bile following administration of (Fig. 4) ; the transacylation of SB-209247 sulphoxide glucuronide at pH 7.4 being somewhat faster than that of SB-209247 glucuronide (Fig. 5) . The single peaks in the mass chromatograms of bile incubated at pH 5.0 (Fig. 4) metabolites ( Fig. 2C ; Table 2 ). However, no sulphoxide glucuronide was detected in the incubations of dog hepatocytes.
Toxicity of SB-209247 to Rat and Dog Liver Slices. Control precision-cut dog and rat liver slices remained viable in Waymouth's medium for 24 h as assessed by low (5-10 % of total) levels of LDH leakage into the medium. SB-209247 caused dose-and time-dependant cellular injury to both the rat and dog tissue over 24 h (Fig. 6) . Similar results were obtained when leakage of aspartate aminotransferase was monitored (data not shown). Although LDH leakage -especially from the rat liver tissue -may have occurred within 2 h at the highest concentration of SB-209247
(1 mM), severe toxicity, entailing leakage of 93-94 % of the LDH (mean of 87 and 100 % for rat slices; 89 and 96 % for dog slices), was only evident with SB-209247 at 1 mM over 24 h. In a positive-control incubation, acetaminophen, at 27 mM, caused only 16-21 % leakage of LDH from rat and dog liver slices over 24 h, but 100 % leakage was attained at 90 mM. 
Microsomal Metabolism of [

Discussion
We have shown that SB-209247, a carboxylic acid NSAID associated in beagle dogs with a predominantly inflammatory hepatopathy, is metabolised extensively to an unstable acyl glucuronide in the rat and by rat, dog and human hepatic microsomes. SB-209247 was also metabolised in rats to the acyl glucuronide of its sulphoxide. In rat bile, under mild alkaline conditions, the sulphoxide conjugate was the more labile of the two glucuronides. Isolated rat and dog hepatocytes replicated most of these pathways but sulphoxide glucuronidation was much lower in rat hepatocytes and not detected in dog hepatocytes. Although a great variety of xenobiotics with alkylcarboxyl or alkenylcarboxyl moieties (Wieland et al., 2000; Soars et al., 2001; Prueksaritanont et al., 2002) are substrates for acyl glucuronidation, this would appear to be the first report of glucuronidation of a propenoic acid group. LC-MS profiling of rat bile for indications of an alternative bioactivation pathway failed to detect S-glutathione thioester conjugates of SB-209247 and its sulphoxide derived from putative acyl-CoA intermediates (Boelsterli, 2002) .
SB-209247 has potent oral anti-inflammatory activity, having an ED 50 of 32 µmol/kg in the murine arachidonic acid-induced ear inflammation model (Daines et al., 1996) . As the two acyl glucuronide metabolites were eliminated in rat bile when doses of 10 and 100 µmol/kg SB-209247 were given i.v., it seems likely that they are both formed at pharmacologically active doses.
The kinetic parameters of glucuronidation indicated that dog liver microsomes have a greater capacity to form SB-209247 acyl glucuronide than either rat or human microsomes. The rank order dog > human for V max of this reaction conformed broadly with the finding of Soars et al. (2001) that the maximum rates of glucuronidation of a structurally diverse group of drugs, including five carboxylic acids (one benzoic and four alkylcarboxylic acids), were at least five-fold greater in dog than human liver microsomes. They also found that the affinity of microsomal UGT for these drugs did not exhibit this relationship but instead was specific to the compound. Consequently their estimates of higher intrinsic clearance by dog microsomes, as calculated from V max /K m , were principally a reflection of differences in V max . However, when the intrinsic clearances of SB-209247 by dog, rat and human liver microsomes, namely 37, 27 and 13 µl/min/mg, respectively, were estimated, it was found that the disparities in V max values were partly counterbalanced by an opposite trend in K m . Other, smaller scale comparisons of glucuronidation in hepatic microsomes from these three species have not found a consistent species-related rank order of UGT activity against phenolic This article has not been copyedited and formatted. The final version may differ from this version. and carboxylate substrates (Ward et al., 1999; Prueksaritanont et al., 2002) . Additionally, a species-related difference between the extents of acyl glucuronidation of a benzoic acid drug in rat and dog liver slices is reversed in vivo (Howell et al., 2001 ). An instance of a benzoic acid acyl glucuronide being formed in humans but in neither dogs nor rats has been reported (Dahms et al., 1997) . The concentration-dependent toxicity of SB-209247 against rat and dog liver slices, assessed as cellular necrosis via cytoplasmic enzyme leakage, did not exhibit the clear species difference in hepatotoxicity obtained during chronic (28-day) toxicity studies: exposure over 24 h to drug concentrations (10-1000 µM) that were approximately 3-150 times the maximum plasma concentrations measured in the dogs (6.8-32 .9 µM from doses of 0.13-2.17 mmol/kg/day; SmithKline Beecham Pharmaceuticals, unpublished data) revealed that hepatocytes in slices from these species are equally sensitive to SB-209247.
This is not irreconcilable with the drug's toxicity in vivo because the dominant feature of the hepatopathy seen in dogs but not in rats was neutrophil infiltration unrelated to dose; only minimal necrosis being observed even in the more severely affected dogs. Neither of these effects, though not necessarily the toxicity toward liver slices, can be easily related to a combination of hepatic microsomal glucuronidation (dog > rat) and protein adduction (dog ≅ rat) as measured here. It is of course possible the drug's toxicity in vivo is a function of a particular subcellular fraction of the protein binding. In this context it is notable that the cytotoxicity of diclofenac towards isolated rat hepatocytes has been linked with oxidative bioactivation rather than protein binding by the drug's acyl glucuronide (Kretz-Rommel and Boelsterli, 1993; Bort et al., 1999) .
However, SB-209247 was not a substrate for NADPH-dependent activation to protein-binding intermediates in either dog, rat or human hepatic microsomes. Acyl glucuronides might also be allowed a hypothetical causal role in the adverse reactions of SB-209247 if it is assumed the complete mechanism was not represented at the hepatocellular level in these experiments. Thus mechanisms requiring accumulation of drug-protein adducts during chronic exposure to elicit the inflammatory hepatopathy would not have been responsible for the cytotoxicity of SB-209247 observed over 24 h.
A local inflammatory response to chemically induced hepatocellular injury, which commonly includes neutrophil recruitment by chemokines, may seemingly contribute to the tissue damage (Smith et al., 1998) or promote regeneration (James et al., 2003) . With acetaminophen, neutrophils infiltrate the liver parallel to or slightly after the appearance of necrosis but in this and other instances it has been suggested that the inflammation is sufficient to maintain recruitment of neutrophils but not to cause additional injury (Copple et al., 2003; James et al., 2003) . In the case of SB-209247, however, the inflammation apparently neither requires induction by persistent hepatocellular necrosis nor results in such damage in most cases. As a high-affinity selective antagonist of LTB 4 binding to neutrophils (Daines et al., 1996) , SB-209247 would be expected to block any LTB 4 -mediated neutrophilic sequestration in response to drug-induced liver injury (Fretland et al., 1995; Brooks and Summers, 1996; Davis et al., 2001 ). The inhibitory activities of the drug's metabolites are unknown; the ether glucuronide of one LTB 4 receptor antagonist (BIIL 284) does retain considerable pharmacological activity (Birke et al., 2001) . The possibility of a pharmacological component in the species-selective neutrophilic inflammatory response to SB-209247 is suggested by the appreciably lower affinity of canine than rat neutrophil LTB 4 receptors for BIIL 284 (Birke et al., 2001) . Nevertheless a hypothetical initiating or modulating role for acyl glucuronides of SB-209247 in the hepatic inflammation can be constructed by analogy with the actions of other drugs. Thus, the acyl glucuronide of mycophenolic acid, but not the aglycone, induces release of pro-inflammatory cytokines from leukocytes (Wieland et al., 2000) .
This article has not been copyedited and formatted. The final version may differ from this version. Certain of these mediators can up-regulate neutrophil adhesion molecules involved in sequestration in the liver (Essani et al., 1997) .
In conclusion, although acyl glucuronidation of SB-209247 is a major hepatocellular biotransformation that leads to protein binding, and SB-209247 is toxic in canine liver slices, these findings alone are insufficient to propose that glucuronidation and/or protein adduction initiate the drug's distinctive hepatopathy in dogs. The possibility that the cytotoxicity obtained with both dog and rat liver slices is connected with irreversible binding of SB-209247 to hepatocellular protein is not excluded. However, the conventional hypothesis of the role of acyl glucuronides in hepatotoxicity -protein adduction leading directly or indirectly to cellular death (Boelsterli, 2002; Bailey and Dickinson et al., 2003) -appears not to apply to SB-209247 because the predominant feature of its hepatotoxicity is accumulation of neutrophils in the apparent absence of tissue damage. The minimal necrosis observed in the more severely affected livers might even have been a consequence of cytotoxic neutrophil activity rather than the drug's hepatocytotoxicity.
Alternatively, the inflammatory response associated with chronic dosing might have been triggered by damaged hepatocytes which, in most of the dogs, were removed within the period of drug administration.
Clearly, the possibility that SB-209247 or its acyl glucuronide can initiate a species-selective hepatic recruitment of inflammatory cells by pathways not involving tissue damage merits further consideration.
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